Effectiveness of an organized bowel management program in the management of severe chronic constipation in children

Katie W Russell1, Douglas C Barnhart1, Sarah Zobell1

  • 1University of Utah, Division of Pediatric Surgery, Primary Children's Hospital, 100 North Mario Capecchi Drive, Suite 2600, Salt Lake City, UT 84113.

Insights

A structured bowel management program significantly reduced hospital admissions by 82% in children with severe chronic constipation. This effective approach offers a new treatment option for refractory pediatric constipation.

Area of Science:

  • Pediatric Gastroenterology
  • Colorectal Surgery
  • Bowel Management

Background:

  • Chronic constipation affects many children, often with idiopathic causes.
  • Standard treatments like laxatives and enemas are frequently ineffective in severe cases.
  • Refractory constipation necessitates advanced management strategies.

Purpose of the Study:

  • To evaluate the effectiveness of a structured bowel management program for children with severe chronic constipation.
  • To assess the program's impact on hospital admissions.

Main Methods:

  • Retrospective review of pediatric patients with chronic constipation.
  • Implementation of a tailored, intensive bowel management program with daily radiographic assessment.
  • Comparison of hospital admission rates before and after program initiation using Fisher's exact test.

Main Results:

  • Fifty percent of 44 children with refractory constipation experienced prior hospitalizations.
  • The program involved high-dose laxatives or enemas, adjusted based on response.
  • Hospital admissions decreased by 82% (from 50% to 9%) after program enrollment (p<0.001).

Conclusions:

  • A structured bowel management program is effective for severe pediatric constipation.
  • This approach significantly reduces hospital admissions in affected children.
  • The program offers a viable alternative for managing refractory pediatric constipation.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
897
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
951
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
1.0K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
950
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
863